Details of the Drug

General Information of Drug (ID: DMBY7AZ)

Drug Name
ACEA-1011
Synonyms Glystatin series member (1011), CoCensys
Indication
Disease Entry ICD 11 Status REF
Cerebral infarction 8B11.5Z Terminated [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 264.59
Logarithm of the Partition Coefficient (xlogp) 2
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C9H4ClF3N2O2
IUPAC Name
5-chloro-7-(trifluoromethyl)-1,4-dihydroquinoxaline-2,3-dione
Canonical SMILES
C1=C(C=C(C2=C1NC(=O)C(=O)N2)Cl)C(F)(F)F
InChI
InChI=1S/C9H4ClF3N2O2/c10-4-1-3(9(11,12)13)2-5-6(4)15-8(17)7(16)14-5/h1-2H,(H,14,16)(H,15,17)
InChIKey
JDCKMCIQUXTYQI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
127872
CAS Number
153504-72-4
TTD ID
D0KJ4U
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
N-methyl-D-aspartate receptor (NMDAR) TT9IK2Z NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007916)
2 NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res. 1993 Jul 2;615(2):331-4.